UNSPSC 51101675: Ontianil

This classification denotes an antihelminthic agent with the molecular formula C13H12ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CWD6R2J64D, chemically known as 2,6-dioxocyclohexanethiocarboxylic acid 4-chloroanilide but generally known as ontianil, which bears US NIH Compound Identifier 3033959. European Medicines Agency schedules Ontianil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09447MIG.

UNSPSC 51101675 Ontianil is a Commodity code covering pharmaceutical products procured by state and local health authorities, including naloxone, generic multi-source pharmaceuticals, over-the-counter medications, and medical supplies for emergency response and community health programs. State and local governments buy these products through direct vendor relationships and cooperative purchasing agreements to support emergency medical services, fire department rescue operations, pharmacy benefit programs, and public health initiatives. Issuing bodies span state health and human services commissions, county health departments, city fire departments, and multistate cooperative purchasing alliances; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and Texas Health and Human Services Commission appear as active procurers in recent notices. Work solicited includes procurement of naloxone and drug deactivation systems for county community health programs, medical and first aid supplies for municipal fire rescue divisions, generic pharmaceuticals through statewide cooperative agreements, and exploratory procurement of direct-to-manufacturer prescription fulfillment programs to support health benefit optimization.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford. The City of Tampa released IFB 26P00145 on March 25, 2026 (response due March 13, 2026) for 169 line items of medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and medical consumables for the Tampa Fire Department Rescue Division, with an estimated contract amount of $700,000 and exclusive set-aside for certified Small Local Business Enterprises. The Minnesota Department of Administration's MMCAP issued RFP S1070000015802 on January 20, 2026 (response due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers with awards effective July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to explore vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements.